As of 2026-04-03, 依沃西单抗's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 1.43%, below the industry average by 2.0 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Positive mention rate (1.43%) is slightly higher than negative (0.00%), continue monitoring public sentiment. Among 6 competitors in the same category, 依沃西单抗's overall mention rate surpasses 3 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
依沃西单抗's Mention Rate is 1.43%, lower than 0.6% of competitors
依沃西单抗's First Mention is 0.00%, lower than 0.9% of competitors
依沃西单抗's Preferred Rate is 0.00%, lower than 100.0% of competitors
依沃西单抗's Positive Rate is 1.43%, lower than 8.9% of competitors
依沃西单抗's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| RRinvoq | 18.57% | 0% | 0% | 7.14% | 0% | View Details |
| 度度普利尤单抗 | 8.57% | 0% | 0% | 7.14% | 0% | View Details |
| KKeytruda | 7.14% | 0% | 0% | 4.29% | 0% | View Details |
| 依依沃西单抗 (Current Brand) | 1.43% | 0% | 0% | 1.43% | 0% | View Details |
| DDarzalex | 0% | 0% | 0% | 0% | 0% | View Details |
| EEnhertu | 0% | 0% | 0% | 0% | 0% | View Details |
| 利利妥昔单抗 | 0% | 0% | 0% | 0% | 0% | View Details |
